IBERCAJA SANIDAD, FI
•CLASE A
Cartera Renta Variable
| 2024-Q2 | ||||
|---|---|---|---|---|
1 | ELI LILLY AND CO | 31.269.542 € | 9.76% | 22.1% |
2 | NOVO NORDISK AS CLASS B | 20.051.589 € | 6.26% | 2.55% |
3 | MERCK & CO INC | 18.358.871 € | 5.73% | 32.12% |
4 | UNITEDHEALTH GROUP INC | 14.023.308 € | 4.38% | 6.92% |
5 | ASTRAZENECA PLC | 12.509.502 € | 3.9% | 43.34% |
6 | ROCHE HOLDING AG | 10.107.969 € | 3.15% | 48.07% |
7 | INTUITIVE SURGICAL INC | 9.758.214 € | 3.04% | 21.16% |
8 | EDWARDS LIFESCIENCES CORP | 9.053.346 € | 2.82% | 87.24% |
9 | MERCK KGAA | 7.995.778 € | 2.49% | 36.4% |
10 | JOHNSON & JOHNSON | 7.940.364 € | 2.48% | 44.19% |
11 | NOVARTIS AG REGISTERED SHARES | 7.757.504 € | 2.42% | 13% |
12 | PFIZER INC | 7.730.869 € | 2.41% | 33.54% |
13 | ABBVIE INC | 7.375.216 € | 2.3% | 51.38% |
14 | THERMO FISHER SCIENTIFIC INC | 7.071.875 € | 2.21% | 7.35% |
15 | MEDTRONIC PLC | 6.863.706 € | 2.14% | 43.72% |
16 | INSULET CORP | 6.739.099 € | 2.1% | 15.92% |
17 | BRISTOL-MYERS SQUIBB CO | 6.650.305 € | 2.08% | 53.33% |
18 | BECTON DICKINSON & CO | 6.544.665 € | 2.04% | 48.15% |
19 | AMGEN INC | 6.499.532 € | 2.03% | 22.8% |
20 | QIAGEN NV | 6.172.433 € | 1.93% | 53.37% |
21 | BOSTON SCIENTIFIC CORP | 5.894.539 € | 1.84% | 10.35% |
22 | DANAHER CORP | 5.364.090 € | 1.67% | 11.29% |
23 | ABBOTT LABORATORIES | 5.101.900 € | 1.59% | 29.52% |
24 | GILEAD SCIENCES INC | 5.033.834 € | 1.57% | 55.34% |
25 | VERTEX PHARMACEUTICALS INC | 5.031.532 € | 1.57% | 40.65% |
26 | SIEMENS HEALTHINEERS AG REGISTERED SHARES | 4.626.800 € | 1.44% | 32.34% |
27 | BIOGEN INC | 4.598.315 € | 1.43% | 7.69% |
28 | SANOFI SA | 4.453.649 € | 1.39% | 55.51% |
29 | UCB SA | 4.417.734 € | 1.38% | 65.41% |
30 | ELEVANCE HEALTH INC | 4.349.852 € | 1.36% | 69.69% |
31 | LONZA GROUP LTD | 4.073.301 € | 1.27% | Nueva |
32 | IQVIA HOLDINGS INC | 3.947.354 € | 1.23% | 54.07% |
33 | ZIMMER BIOMET HOLDINGS INC | 3.748.352 € | 1.17% | 40.35% |
34 | ZOETIS INC CLASS A | 3.721.908 € | 1.16% | 25.65% |
35 | ESSILORLUXOTTICA | 3.634.477 € | 1.13% | 50.91% |
36 | GSK PLC | 3.466.819 € | 1.08% | 39.34% |
37 | SMITH & NEPHEW PLC | 3.343.480 € | 1.04% | 72.51% |
38 | SONOVA HOLDING AG | 3.046.495 € | 0.95% | 2.34% |
39 | THE CIGNA GROUP | 2.761.384 € | 0.86% | 36.17% |
40 | AGILENT TECHNOLOGIES INC | 2.480.552 € | 0.77% | 3.92% |
41 | HCA HEALTHCARE INC | 2.324.504 € | 0.73% | 35.73% |
42 | 武田薬品工業株式会社 | 2.179.134 € | 0.68% | 6.44% |
43 | BAXTER INTERNATIONAL INC | 1.486.250 € | 0.46% | 74.68% |
44 | ILLUMINA INC | 1.369.908 € | 0.43% | 22.75% |
45 | ALCON INC | 1.277.823 € | 0.4% | 40.34% |
46 | GRAIL INC | 33.615 € | 0.01% | Nueva |
| 2024-Q4 | ||||
|---|---|---|---|---|
1 | ELI LILLY AND CO | 26.844.393 € | 8.81% | 14.15% |
2 | MERCK & CO INC | 17.187.085 € | 5.64% | 6.38% |
3 | UNITEDHEALTH GROUP INC | 14.414.054 € | 4.73% | 2.79% |
4 | NOVO NORDISK AS CLASS B | 12.446.835 € | 4.09% | 37.93% |
5 | INTUITIVE SURGICAL INC | 11.847.832 € | 3.89% | 21.41% |
6 | ROCHE HOLDING AG | 10.620.317 € | 3.49% | 5.07% |
7 | EDWARDS LIFESCIENCES CORP | 8.938.230 € | 2.93% | 1.27% |
8 | ASTRAZENECA PLC | 8.333.803 € | 2.74% | 33.38% |
9 | JOHNSON & JOHNSON | 8.129.899 € | 2.67% | 2.39% |
10 | MEDTRONIC PLC | 7.979.513 € | 2.62% | 16.26% |
11 | ABBVIE INC | 7.906.646 € | 2.6% | 7.21% |
12 | BECTON DICKINSON & CO | 7.669.709 € | 2.52% | 17.19% |
13 | PFIZER INC | 7.585.125 € | 2.49% | 1.89% |
14 | NOVARTIS AG REGISTERED SHARES | 7.341.068 € | 2.41% | 5.37% |
15 | MERCK KGAA | 7.228.493 € | 2.37% | 9.6% |
16 | BOSTON SCIENTIFIC CORP | 7.074.510 € | 2.32% | 20.02% |
17 | GILEAD SCIENCES INC | 7.012.733 € | 2.3% | 39.31% |
18 | QIAGEN NV | 6.892.150 € | 2.26% | 11.66% |
19 | THERMO FISHER SCIENTIFIC INC | 6.884.141 € | 2.26% | 2.65% |
20 | ELEVANCE HEALTH INC | 6.485.057 € | 2.13% | 49.09% |
21 | ABBOTT LABORATORIES | 5.746.727 € | 1.89% | 12.64% |
22 | AMGEN INC | 5.610.318 € | 1.84% | 13.68% |
23 | DANAHER CORP | 5.099.633 € | 1.67% | 4.93% |
24 | SMITH & NEPHEW PLC | 5.024.939 € | 1.65% | 50.29% |
25 | BRISTOL-MYERS SQUIBB CO | 4.837.620 € | 1.59% | 27.26% |
26 | UCB SA | 4.776.362 € | 1.57% | 8.12% |
27 | SANOFI SA | 4.641.817 € | 1.52% | 4.23% |
28 | LONZA GROUP LTD | 4.566.169 € | 1.5% | 12.1% |
29 | VERTEX PHARMACEUTICALS INC | 4.473.148 € | 1.47% | 11.1% |
30 | SIEMENS HEALTHINEERS AG REGISTERED SHARES | 4.403.200 € | 1.45% | 4.83% |
31 | ESSILORLUXOTTICA | 4.255.878 € | 1.4% | 17.1% |
32 | IQVIA HOLDINGS INC | 3.796.194 € | 1.25% | 3.83% |
33 | ZIMMER BIOMET HOLDINGS INC | 3.775.051 € | 1.24% | 0.71% |
34 | ZOETIS INC CLASS A | 3.619.618 € | 1.19% | 2.75% |
35 | INSULET CORP | 3.599.957 € | 1.18% | 46.58% |
36 | SONOVA HOLDING AG | 3.336.307 € | 1.1% | 9.51% |
37 | BIOGEN INC | 3.138.752 € | 1.03% | 31.74% |
38 | GSK PLC | 3.129.297 € | 1.03% | 9.74% |
39 | AGILENT TECHNOLOGIES INC | 2.660.070 € | 0.87% | 7.24% |
40 | THE CIGNA GROUP | 2.386.919 € | 0.78% | 13.56% |
41 | 武田薬品工業株式会社 | 2.311.103 € | 0.76% | 6.06% |
42 | HCA HEALTHCARE INC | 2.247.139 € | 0.74% | 3.33% |
43 | ILLUMINA INC | 1.814.776 € | 0.6% | 32.47% |
44 | BAXTER INTERNATIONAL INC | 1.340.690 € | 0.44% | 9.79% |
45 | ALCON INC | 1.256.804 € | 0.41% | 1.64% |
46 | GRAIL INC | 0 € | Vendida | |
Cartera ICC
| 2024-Q2 | ||||
|---|---|---|---|---|
1 | CANDRIAM EQUITIES L BIOTECHNOLOGY CLASS V USD CAP | 5.601.808 € | 1.75% | 56.86% |
| 2024-Q4 | ||||
|---|---|---|---|---|
1 | CANDRIAM EQUITIES L BIOTECHNOLOGY CLASS V USD CAP | 5.635.152 € | 1.85% | 0.6% |